Top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
19 June 2013 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb announced top-line results...
List view / Grid view
19 June 2013 | By AstraZeneca
AstraZeneca and Bristol-Myers Squibb announced top-line results...
19 June 2013 | By Sanofi
Preclinical program of translational research to identify new target proteins...
18 June 2013 | By GlaxoSmithKline
GlaxoSmithKline has received an offer for its thrombosis brands...
18 June 2013 | By Daiichi Sankyo
The application is based on the results of a phase 3 trial...
18 June 2013 | By Sanofi
"an important opportunity for Sanofi to share significant data..."
18 June 2013 | By AstraZeneca
"AstraZeneca’s investment is excellent news for the UK life sciences industry..."
17 June 2013 | By Johnson & Johnson
Late-stage prostate cancer treatment strengthens oncology pipeline...
17 June 2013 | By Gilead Sciences, Inc.
Gilead Sciences announced interim results from a single-arm, open-label Phase 2 study evaluating idelalisib...
17 June 2013 | By Boehringer Ingelheim
New long-term data from the RELY-ABLE® study...
17 June 2013 | By Teva Pharmaceutical Industries Ltd.
Teva has entered into a definitive agreement to acquire MicroDose Therapeutx...
17 June 2013 | By BMG LABTECH
Over the years, many different assays have been designed...
17 June 2013 | By AstraZeneca
MedImmune and NGM Biopharmaceuticals have entered into an exclusive agreement...
17 June 2013 | By Novartis
The Novartis Prizes for Immunology are awarded to three scientists...
17 June 2013 | By Roche
First approval of Avastin for the treatment of newly diagnosed glioblastoma...
16 June 2013 | By Novartis
Results from a Phase III three-year follow-up study...